Approval · Notice of Compliance 17496 · 2015
PROGRAM SUSPENSION: Notice of Compliance 17496
Issued November 20, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17496
- Date
- November 20, 2015
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Therapeutic class
- Insect development inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGRAM SUSPENSION | 02057832 | Cancelled Post Market |
Medicinal ingredients
- LUFENURON 133 MG per DOSE